东阳光药调整销售架构，欲发力肝病业务

Core Viewpoint - Dongyang Sunshine Pharmaceutical has made strategic adjustments to its sales structure by establishing a dedicated team for liver disease, aiming to accelerate the commercialization of innovative drugs for hepatitis C amidst fierce competition in the influenza drug market [3]. Group 1 - The company has recently formed a specialized team focused on liver diseases to enhance its market presence [3]. - This move is part of the company's strategy to seek new growth points in response to intense competition in the influenza drug sector [3].